Shanghai Fosun Pharmaceutical (Group) , Ltd. Current Assets

Shanghai Fosun Pharmaceutical (Group) , Ltd. (2196.HK) currently reports a current assets of $35B as of June 2026. That compares with $34B in the prior-year period — up 1.3% year over year. Use the charts on this page to explore Shanghai Fosun Pharmaceutical (Group) , Ltd.'s current assets history and peer comparisons.

Shanghai Fosun Pharmaceutical (Group) , Ltd.'s current assets increased from $34B to $35B — a 1.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shanghai Fosun Pharmaceutical (Group) , Ltd. reported $35B in current assets as of June 2026. That compares with $34B in the prior-year period — up 1.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $35B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shanghai Fosun Pharmaceutical (Group) , Ltd., and consider following 2196.HK for alerts when major investors trade the stock.